NCT00402909View on ClinicalTrials.gov

Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Type 2 Diabetes
Interventions
DRUG

Nateglinide

Trial Locations (1)

07974

Novartis Pharmaceuticals, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY